US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PELTHOS THERAPEUTICS INC

25.51

-1.1500-4.31%

Post-market: 25.510.00000.00%19:30 EDT

Volume:21.64K

Turnover:569.12K

Market Cap:97.67M

PE:-0.97

High:28.47

Open:26.41

Low:25.00

Close:26.66

52wk High:37.50

52wk Low:18.19

Shares:3.83M

Float Shares:1.07M

Volume Ratio:0.93

T/O Rate:2.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-26.3603

EPS(LYR):-23.0359

ROE:-333.84%

ROA:-49.98%

PB:-65.07

PE(LYR):-1.11

Loading ...

Overview Company News Filings

Pelthos Therapeutics Announces Annual Shareholder Meeting

Scienture Q2 Revenue Surges on Rezenopy Launch

Pelthos Therapeutics (PTHS) Gets a Buy from Alliance Global Partners

Pelthos Therapeutics Falls as Co Says Will Restate Q1 Financial Statements

Biofrontera Q2 Revenue Rises on Higher Volume, Pricing

Pelthos Therapeutics Posts Investor Deck Outlining Dermatology Portfolio Strategy Centered on Zelsuvmi Launch, Xepi and Xeglyze Additions

Pelthos Therapeutics Q2 Revenue Rises on Zelsuvmi Adoption

Pelthos Q2 FY26 Net Loss Narrows to $23.42 Million; Net Product Revenue Climbs 45% to $15.4 Million

Pelthos Therapeutics Q2 Net Income USD -23.417 Million

THOMSON REUTERS

Pelthos Therapeutics Announces Second Quarter 2026 Financial Results

THOMSON REUTERS

Pelthos Therapeutics Restates Q1 2026 Net Loss to USD 25.07 Million

Pelthos Restates Q1 Results After ASC 820 Error Lifts Convertible Debt Fair Value by $15.8 Million

Pelthos Therapeutics - Restatement Will not Impact Liquidity or Cash Position for Quarter Ended March 31, 2026 - SEC Filing

THOMSON REUTERS

Pelthos Therapeutics - Financial Statements Should no Longer be Relied upon for Quarter Ended March 31- SEC Filing

THOMSON REUTERS

Pelthos Therapeutics - Identifies Material Weakness in Internal Control as of March 31, 2026 - SEC Filing

THOMSON REUTERS

Pelthos Therapeutics - to Restate Financial Statements for Affected Period

THOMSON REUTERS

Pelthos Therapeutics Announces Annual Shareholder Meeting

Press Release: Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026

Press Release: Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders

Analysts’ Opinions Are Mixed on These NA Stocks: Sunbelt Rentals Holdings Inc (SUNB) and Pelthos Therapeutics (PTHS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PTHS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTHS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","market":"US","secType":"STK","nameCN":"PELTHOS THERAPEUTICS INC","latestPrice":25.51,"timestamp":1787342400000,"preClose":26.66,"halted":0,"volume":21635,"hourTrading":{"tag":"盘后","latestPrice":25.51,"preClose":25.51,"latestTime":"19:30 EDT","volume":124,"amount":3163.24,"timestamp":1787355007026,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.043135783945986446,"floatShares":1065500,"shares":3828500,"eps":-26.360256,"marketStatus":"Market Closed","change":-1.15,"latestTime":"08-21 16:00:00 EDT","open":26.41,"high":28.4731,"low":25,"amount":569123.9060399999,"amplitude":0.130274,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-26.360256,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":26.66,"postHourTrading":{"tag":"盘后","latestPrice":25.51,"preClose":25.51,"latestTime":"19:30 EDT","volume":124,"amount":3163.24,"timestamp":1787355007026,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9347187410915764},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","floatShares":1065500,"roa":"-49.98%","roe":"-333.84%","lyrEps":-23.035919,"volumeRatio":0.9347187410915764,"shares":3828500,"dividePrice":0,"high":28.4731,"amplitude":0.130274,"preClose":26.66,"low":25,"week52Low":18.19,"pbRate":"-65.07","psRate":"2.26","week52High":37.5,"institutionHeld":0,"latestPrice":25.51,"eps":-26.360256,"divideRate":0,"volume":21635,"delay":0,"ttmEps":-26.360256,"open":26.41,"prevYearClose":31,"prevWeekClose":27.5,"prevMonthClose":28.66,"prevQuarterClose":28.26,"fiveDayClose":27.5,"twentyDayClose":25.92,"sixtyDayClose":26.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTHS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PTHS","fiscalQuarterEnding":"2026/06","expectedEps":-3.02,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-6.62},{"market":"US","date":"2026-05-14","symbol":"PTHS","fiscalQuarterEnding":"2026/03","expectedEps":4,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"pre","actualEps":-3.09},{"market":"US","date":"2026-03-19","symbol":"PTHS","fiscalQuarterEnding":"2025/12","expectedEps":-3.95,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":-2.83},{"market":"US","date":"2025-11-13","symbol":"PTHS","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-5.3},{"market":"US","date":"2025-07-02","symbol":"PTHS","defaultRemindTime":1751463000000,"type":"split","dateTimestamp":1751428800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTHS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1775102400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTHS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTHS","date":"2026-08-21","current":-0.967745,"percent":0.985965,"low":-12.702408,"twenty":-4.332389,"median":-2.094939,"eighty":-1.781447,"high":-1.038767,"avg":-3.932093,"sd":3.341943,"marketCap":102066983},"quantilePoints":[{"date":"2025-07-03","current":-1.450338,"twenty":-1.398151,"median":-1.319871,"eighty":-1.241591,"marketCap":10675383},{"date":"2025-07-11","current":-2.372872,"twenty":-2.216593,"median":-1.475876,"eighty":-1.450338,"marketCap":17465810},{"date":"2025-07-18","current":-1.983069,"twenty":-1.968731,"median":-1.794665,"eighty":-1.455446,"marketCap":14596616},{"date":"2025-07-25","current":-1.97142,"twenty":-1.96909,"median":-1.819083,"eighty":-1.509032,"marketCap":14510870},{"date":"2025-08-01","current":-1.895251,"twenty":-1.972137,"median":-1.894355,"eighty":-1.668896,"marketCap":13950222},{"date":"2025-08-08","current":-1.785927,"twenty":-1.971241,"median":-1.88181,"eighty":-1.778579,"marketCap":13145529},{"date":"2025-08-15","current":-1.383693,"twenty":-1.968373,"median":-1.828044,"eighty":-1.653842,"marketCap":12505731},{"date":"2025-08-22","current":-1.565412,"twenty":-1.958336,"median":-1.793992,"eighty":-1.534031,"marketCap":14148098},{"date":"2025-08-29","current":-7.738365,"twenty":-1.968373,"median":-1.78996,"eighty":-1.553735,"marketCap":69938867},{"date":"2025-09-05","current":-10.936036,"twenty":-1.983069,"median":-1.813483,"eighty":-1.562493,"marketCap":98839226},{"date":"2025-09-12","current":-10.771103,"twenty":-7.559968,"median":-1.868816,"eighty":-1.565412,"marketCap":97348576},{"date":"2025-09-19","current":-11.212045,"twenty":-9.357396,"median":-1.887634,"eighty":-1.641655,"marketCap":101333783},{"date":"2025-09-26","current":-11.188484,"twenty":-10.771103,"median":-1.911381,"eighty":-1.642041,"marketCap":101120833},{"date":"2025-10-03","current":-8.961188,"twenty":-10.771103,"median":-1.965147,"eighty":-1.648609,"marketCap":80990668},{"date":"2025-10-10","current":-8.414925,"twenty":-10.626367,"median":-1.972316,"eighty":-1.659169,"marketCap":76053575},{"date":"2025-10-17","current":-9.593014,"twenty":-10.434506,"median":-2.154672,"eighty":-1.70259,"marketCap":86701075},{"date":"2025-10-24","current":-11.663085,"twenty":-10.626367,"median":-7.559968,"eighty":-1.70259,"marketCap":105410254},{"date":"2025-10-31","current":-11.19185,"twenty":-10.777835,"median":-7.80905,"eighty":-1.706174,"marketCap":101151254},{"date":"2025-11-07","current":-12.702408,"twenty":-10.936036,"median":-7.98408,"eighty":-1.777862,"marketCap":114803587},{"date":"2025-11-14","current":-11.772301,"twenty":-11.111066,"median":-8.995487,"eighty":-1.781447,"marketCap":106397338},{"date":"2025-11-21","current":-3.765213,"twenty":-11.111066,"median":-8.414925,"eighty":-1.785927,"marketCap":88788749},{"date":"2025-11-28","current":-3.687312,"twenty":-11.108373,"median":-7.960687,"eighty":-1.792379,"marketCap":86951740},{"date":"2025-12-05","current":-3.422448,"twenty":-11.024224,"median":-7.763609,"eighty":-1.805104,"marketCap":80705911},{"date":"2025-12-12","current":-3.133628,"twenty":-10.952193,"median":-4.332389,"eighty":-1.816843,"marketCap":73895143},{"date":"2025-12-19","current":-2.967391,"twenty":-10.936709,"median":-3.83078,"eighty":-1.833421,"marketCap":69975058},{"date":"2025-12-26","current":-3.468719,"twenty":-10.936036,"median":-3.687312,"eighty":-1.856092,"marketCap":81797046},{"date":"2026-01-02","current":-4.057747,"twenty":-10.93065,"median":-3.642809,"eighty":-1.874014,"marketCap":95687111},{"date":"2026-01-09","current":-3.672916,"twenty":-10.883527,"median":-3.665062,"eighty":-1.88181,"marketCap":86612268},{"date":"2026-01-16","current":-3.395418,"twenty":-10.806109,"median":-3.583058,"eighty":-1.88647,"marketCap":80068505},{"date":"2026-01-23","current":-3.187295,"twenty":-10.776489,"median":-3.555764,"eighty":-1.893817,"marketCap":75160682},{"date":"2026-01-30","current":-3.374475,"twenty":-10.771103,"median":-3.506679,"eighty":-1.898477,"marketCap":79574636},{"date":"2026-02-06","current":-3.052604,"twenty":-10.742156,"median":-3.468719,"eighty":-1.919625,"marketCap":71984487},{"date":"2026-02-13","current":-2.833747,"twenty":-10.623674,"median":-3.435432,"eighty":-1.954036,"marketCap":66823556},{"date":"2026-02-20","current":-3.036408,"twenty":-10.612903,"median":-3.401675,"eighty":-1.95977,"marketCap":71602566},{"date":"2026-02-27","current":-3.155779,"twenty":-10.602805,"median":-3.390837,"eighty":-1.970524,"marketCap":74417489},{"date":"2026-03-06","current":-3.074826,"twenty":-10.434506,"median":-3.374475,"eighty":-1.97142,"marketCap":72508518},{"date":"2026-03-13","current":-3.190081,"twenty":-10.434506,"median":-3.360076,"eighty":-1.972316,"marketCap":75226374},{"date":"2026-03-20","current":-1.7154,"twenty":-10.097909,"median":-3.349516,"eighty":-1.97142,"marketCap":74309421},{"date":"2026-03-27","current":-1.761468,"twenty":-9.761313,"median":-3.316998,"eighty":-1.911381,"marketCap":76305047},{"date":"2026-04-02","current":-1.649924,"twenty":-9.626674,"median":-3.312954,"eighty":-1.88181,"marketCap":71473065},{"date":"2026-04-10","current":-1.749075,"twenty":-9.525695,"median":-3.297807,"eighty":-1.833421,"marketCap":75768160},{"date":"2026-04-17","current":-1.781608,"twenty":-9.500787,"median":-3.280885,"eighty":-1.792379,"marketCap":77177489},{"date":"2026-04-24","current":-1.797101,"twenty":-9.439526,"median":-3.26405,"eighty":-1.781608,"marketCap":77848597},{"date":"2026-05-01","current":-1.936531,"twenty":-9.424716,"median":-3.220673,"eighty":-1.782538,"marketCap":83888575},{"date":"2026-05-08","current":-1.938855,"twenty":-9.37086,"median":-3.190081,"eighty":-1.785296,"marketCap":83989241},{"date":"2026-05-15","current":-2.144901,"twenty":-9.354703,"median":-3.188002,"eighty":-1.78619,"marketCap":92914985},{"date":"2026-05-22","current":-1.825776,"twenty":-9.310946,"median":-3.162639,"eighty":-1.782538,"marketCap":94189979},{"date":"2026-05-29","current":-1.738193,"twenty":-9.201215,"median":-3.155779,"eighty":-1.782305,"marketCap":89671641},{"date":"2026-06-05","current":-1.742235,"twenty":-9.106968,"median":-3.138864,"eighty":-1.781608,"marketCap":89880179},{"date":"2026-06-12","current":-1.934919,"twenty":-9.053119,"median":-3.057709,"eighty":-1.781608,"marketCap":99820524},{"date":"2026-06-18","current":-1.819713,"twenty":-9.002347,"median":-3.051164,"eighty":-1.781608,"marketCap":93877171},{"date":"2026-06-26","current":-1.967931,"twenty":-8.742683,"median":-3.016477,"eighty":-1.781608,"marketCap":101523590},{"date":"2026-07-02","current":-1.886411,"twenty":-8.328756,"median":-3.009278,"eighty":-1.781608,"marketCap":97318060},{"date":"2026-07-10","current":-1.829819,"twenty":-7.979401,"median":-2.945794,"eighty":-1.781608,"marketCap":94398518},{"date":"2026-07-17","current":-1.799501,"twenty":-7.934399,"median":-2.91896,"eighty":-1.781608,"marketCap":92834477},{"date":"2026-07-24","current":-1.91336,"twenty":-7.821168,"median":-2.887545,"eighty":-1.781608,"marketCap":98708318},{"date":"2026-07-31","current":-1.76851,"twenty":-7.788854,"median":-2.833747,"eighty":-1.781608,"marketCap":91235681},{"date":"2026-08-07","current":-1.9841,"twenty":-7.738365,"median":-2.592541,"eighty":-1.781608,"marketCap":102357745},{"date":"2026-08-14","current":-1.950414,"twenty":-7.559968,"median":-2.325379,"eighty":-1.781608,"marketCap":100619922},{"date":"2026-08-21","current":-1.18144,"twenty":-4.332389,"median":-2.094939,"eighty":-1.781447,"marketCap":102066983}],"updateTime":1787453674972},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTHS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660492069","title":"Pelthos Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492069?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:01","pubTimestamp":1787086907,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics announces annual shareholder meetingPelthos Therapeutics will hold its 2026 annual shareholder meeting online on Sept. 29, 2026.Shareholders will vote to elect eight directors to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL24dCQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659499201","title":"Scienture Q2 Revenue Surges on Rezenopy Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2659499201","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659499201?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:17","pubTimestamp":1786709821,"startTime":"0","endTime":"0","summary":"Scienture Q2 revenue surges on REZENOPY launchOverviewUS specialty pharma firm's Q2 revenue rose sharply, driven by commercial launch of REZENOPYQ2 gross margin reached 97.7%, reflecting growing comme","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","OMER","PTHS","SCNX","BK4007","BK4139","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169726","title":"Pelthos Therapeutics (PTHS) Gets a Buy from Alliance Global Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169726","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169726?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:35","pubTimestamp":1786642545,"startTime":"0","endTime":"0","summary":"In a report released today, James Molloy from Alliance Global Partners maintained a Buy rating on Pelthos Therapeutics, with a price target of $45....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-gets-a-buy-from-alliance-global-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-gets-a-buy-from-alliance-global-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659655651","title":"Pelthos Therapeutics Falls as Co Says Will Restate Q1 Financial Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2659655651","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659655651?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:18","pubTimestamp":1786634323,"startTime":"0","endTime":"0","summary":"BUZZ-Pelthos Therapeutics falls as co says will restate Q1 financial statements** Shares of Pelthos TherapeuticsPTHS.Afall 1.8% to $28.41 in morning trade** Pelthos says has it has identified a materi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL6N44A13T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315736","title":"Biofrontera Q2 Revenue Rises on Higher Volume, Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315736","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315736?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:01","pubTimestamp":1786626085,"startTime":"0","endTime":"0","summary":"Biofrontera Q2 revenue rises on higher volume, pricingOverviewU.S. biopharmaceutical firm's Q2 revenue grew 33% yr/yr, driven by higher unit volume and pricingNet loss for Q2 narrowed to $0.6 mln from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","BK4139","PTHS","BK4007","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159221","title":"Pelthos Therapeutics Posts Investor Deck Outlining Dermatology Portfolio Strategy Centered on Zelsuvmi Launch, Xepi and Xeglyze Additions","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159221?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:34","pubTimestamp":1786620880,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics posts investor deck outlining dermatology portfolio strategy centered on Zelsuvmi launch, Xepi and Xeglyze additionsPelthos highlighted commercial traction for Zelsuvmi, with more","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL8Q2Y5R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159826","title":"Pelthos Therapeutics Q2 Revenue Rises on Zelsuvmi Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159826","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159826?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:20","pubTimestamp":1786620006,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics Q2 revenue rises on Zelsuvmi adoptionOverviewU.S. biopharmaceutical firm's Q2 net product revenue grew 45% quarter-over-quarterNet loss for Q2 narrowed compared to Q1, adjusted EB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0H6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","LQDA","PLX","BK4139","BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156416","title":"Pelthos Q2 FY26 Net Loss Narrows to $23.42 Million; Net Product Revenue Climbs 45% to $15.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156416","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156416?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619425,"startTime":"0","endTime":"0","summary":"Pelthos Q2 FY26 net loss narrows to $23.42 million; net product revenue climbs 45% to $15.4 millionPelthos posted a GAAP net loss of USD 23.4 million, narrowing from USD 25.1 million in the prior quar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2Y5Dcz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014021.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","BK4585","BCDF","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4139","PTHS","SG9999014005.SGD","LU0314104364.USD","SG9999014013.SGD","BK4588","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659468156","title":"Pelthos Therapeutics Q2 Net Income USD -23.417 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659468156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659468156?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLX7BCVP8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156466","title":"Pelthos Therapeutics Announces Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156466?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA8RN9YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659561321","title":"Pelthos Therapeutics Restates Q1 2026 Net Loss to USD 25.07 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659561321","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659561321?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:07","pubTimestamp":1786619257,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics restates Q1 2026 net loss to USD 25.07 millionPelthos filed a Form 10-Q/A on Aug. 13, 2026, restating unaudited first-quarter 2026 financial statements due to ASC 820 valuation er","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL3FP2CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659715699","title":"Pelthos Restates Q1 Results After ASC 820 Error Lifts Convertible Debt Fair Value by $15.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659715699","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659715699?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:05","pubTimestamp":1786619155,"startTime":"0","endTime":"0","summary":"Pelthos restates Q1 results after ASC 820 error lifts convertible debt fair value by $15.8 millionPelthos flagged non-reliance on its Q1 2026 Form 10-Q due to a misapplication of ASC 820 in Level 3 fair values.Restatement will lift the fair value of convertible debt by $15.8 million, raising liabilities and widening accumulated deficit by $14.8 million.Non-cash expense tied to the convertible debt fair value change will increase by $14.8 million, pressuring reported net loss.Audit committee identified a material weakness in controls over valuation and review of Level 3 measurements tied to the convertible debt.No expected impact on liquidity, cash, revenue, operating expenses, or operating loss; correction sits in other income .Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL8Qz3Fq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659565561","title":"Pelthos Therapeutics - Restatement Will not Impact Liquidity or Cash Position for Quarter Ended March 31, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659565561","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659565561?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:02","pubTimestamp":1786618929,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0NL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659563971","title":"Pelthos Therapeutics - Financial Statements Should no Longer be Relied upon for Quarter Ended March 31- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659563971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659563971?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:02","pubTimestamp":1786618929,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0NL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156653","title":"Pelthos Therapeutics - Identifies Material Weakness in Internal Control as of March 31, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156653?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:02","pubTimestamp":1786618929,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0NL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156367","title":"Pelthos Therapeutics - to Restate Financial Statements for Affected Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156367?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:02","pubTimestamp":1786618929,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0NL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657622629","title":"Pelthos Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2657622629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657622629?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:01","pubTimestamp":1786136488,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics announces annual shareholder meetingPelthos Therapeutics will hold its 2026 annual shareholder meeting online on Sept. 29, 2026.Shareholders will vote to elect eight directors to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL7V4Hry:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656376954","title":"Press Release: Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2656376954","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656376954?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:01","pubTimestamp":1785758460,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., Aug. 03, 2026  -- Pelthos Therapeutics Inc. , a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs , today announced it will report second quarter 2026 financial results on Thursday, August 13, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern Time.Details for the conference call can be found below:","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4539","LENZ","BK4007","BK4022","BK4139","PTHS","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654037691","title":"Press Release: Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2654037691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654037691?lang=en_us&edition=fundamental","pubTime":"2026-07-25 05:00","pubTimestamp":1784926800,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., July 24, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS) (the \"Company\" or \"Pelthos\") today announced that it will hold its 2026 Annual Meeting of Stockholders v","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4022","BK4232","BK4539","PTHS","BK4139","R","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651114572","title":"Analysts’ Opinions Are Mixed on These NA Stocks: Sunbelt Rentals Holdings Inc (SUNB) and Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651114572","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651114572?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:00","pubTimestamp":1783947625,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Sunbelt Rentals Holdings Inc (SUNB) and Pelthos Therapeutics (PTHS). Sunb...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-na-stocks-sunbelt-rentals-holdings-inc-sunb-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-na-stocks-sunbelt-rentals-holdings-inc-sunb-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SUNB","PTHS","NA","BK4139","BK4104","LU0648000940.SGD","LU0477156797.USD","LU1201861165.SGD","LU0130103400.USD","LU0130518102.USD","BK4141"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}]}}